Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis

Environmental and Molecular Mutagenesis

Volumn 50, Issue 5, 2009, Pages 361-366

  Kang, Shan ^a   Zhao, Jian ^a   Liu, Qing ^a   Zhou, Rongmiao ^b   Wang, Na ^b   Li, Yan ^a,b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Hebei Cancer Institute   (China)

Author keywords

Adenomyosis; Polymorphism; Risk; VEGF

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADENOMYOSIS; ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; ENDOMETRIOSIS; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ENDOMETRIOSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 67549123410     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20455     Document Type: Article

References (30)

1. Abe A, Sato K, Habuchi T, Wang L, Li Z, Tsuchiya N, Ohyama C, Satoh S, Ogawa O, Kato T. 2002. Single nucleotide polymorphisms in the 30-untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma. Tohoku J Exp Med 198:181-190. (Pubitemid 36305121)
2. Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, Inoue I, Katayama S. 2002. A common polymorphism in the 50-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51:1635-1639. (Pubitemid 34826636)
3. Bergholt T, Eriksen L, Berendt N, Jacobsen M, Hertz JB. 2001. Prevalence and risk factors of adenomyosis at hysterectomy. Hum Reprod 16:2418-2421. (Pubitemid 33054148)
4. Ferrara N. 2004. Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev 25:581-611. (Pubitemid 39099316)
5. Han SW, Kim GW, Seo JS, Kim SJ, Sa KH, Park JY, Lee J, Kim SY, Goronzy JJ, Weyand CM, Kang YM. 2004. VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology 43:1173-1177. (Pubitemid 39232824)
6. Han Y, Zhou Y, Zheng S. 2002. Study on the expression of vascular endothelial growth factor in patients with adenomyosis of the uterus. Zhonghua Fu Chan Ke Za Zhi 37:539-541.
7. Hefler LA, Mustea A, Könsgen D, Concin N, Tanner B, Strick R, Heinze G, Grimm C, Schuster E, Tempfer C, Reinthaller A, Zeillinger R. 2007. Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer. Clin Cancer Res 13:898-901. (Pubitemid 46340365)
8. Howell WM, Bateman AC, Turner SJ, Collins A, Theaker JM. 2002. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumor development in cutaneous malignant melanoma. Genes Immun 3:229-232. (Pubitemid 38961136)
9. Jacobs EJ, Feigelson HS, Bain EB, Brady KA, Rodriguez C, Stevens VL, Patel AV, Thun MJ, Calle EE. 2006. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res 8:R22. (Pubitemid 44377909)
10. Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R, Henriksson R, Chen B, Pamula J, Pekala W, Zientek H, Rogozinska- Szczepka J, Utracka-Hutka B, Hallmans G, Foärsti A. 2005. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 11:3647-3653.
11. Kawai Y, Sakano S, Korenaga Y, Eguchi S, Naito K. 2007. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas. Eur Urol 52:1147-1155. (Pubitemid 47332024)
12. Koukourakis MI, Papazoglou D, Giatromanolaki A, Bougioukas G, Maltezos E, Sivridis E. 2004. VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 46:293-298. (Pubitemid 39487303)
13. Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Haas J, Samonigg H. 2003. A common 1936C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 106:468-471. (Pubitemid 36966201)
14. Ku KT, Wan L, Peng HC, Tsai MH, Tsai CH, Tsai FJ. 2005. Vascular endothelial growth factor gene 2460 C/T polymorphism is a biomarker for oral cancer. Oral Oncol 41:497-502. (Pubitemid 40692850)
15. Li T, Li YG, Pu DM. 2006. Matrix metalloproteinase-2 and -9 expression correlated with angiogenesis in human adenomyosis. Gynecol Obstet Invest 62:229-235. (Pubitemid 44763191)
16. Lin CC, Wu HC, Tsai FJ, Chen HY, Chen WC. 2003. Vascular endothelial growth factor gene 2460 C/T polymorphism is a biomarker for prostate cancer. Urology 62:374-377. (Pubitemid 36952109)
17. Lu H, Shu XO, Cui Y, Kataoka N, Wen W, Cai Q, Ruan ZX, Gao YT, Zheng W. 2005. Association of genetic polymorphisms in the VEGF gene with breast cancer survival. Cancer Res 65:5015-5019. (Pubitemid 40827307)
18. Matalliotakis IM, Katsikis IK, Panidis DK. 2005. Adenomyosis: What is the impact on fertility? Curr Opin Obstet Gynecol 17:261-264.
19. McCarron SL, Edwards S, Evans PR, Gibbs R, Dearnaley DP, Dowe A, Southgate C, Easton DF, Eeles RA, Howell WM. 2002. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 62:3369-3372. (Pubitemid 34651380)
20. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16:1215
21. Onen IH, Konac E, Eroglu M, Guneri C, Biri H, Ekmekci A. 2008. No association between polymorphism in the vascular endothelial growth factor gene at position -460 and sporadic prostate cancer in the Turkish population. Mol Biol Rep 35:17-22.
22. Parazzini F, Vercellini P, Panazza S, Chatenoud L, Oldani S, Crosignani PG. 1997. Risk factors for adenomyosis. Hum Reprod 12:1275-1279.
23. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. 2000. A common 1936C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37:443-448. (Pubitemid 32037619)
24. Seidman JD, Kjerulff KH. 1996. Pathologic findings from the Maryland Women's Health Study: Practice patterns in the diagnosis of adenomyosis. Int J Gynecol Pathol 15:217-221. (Pubitemid 26227279)
25. Shahbazi M, Fryer AA, Pravica V, Brogan IJ, Ramsay HM, Hutchinson IV, Harden PN. 2002. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 13:260-264. (Pubitemid 34042036)
26. Shaikh H, Khan KS. 1990. Adenomyosis in Pakistani women: Four year experience at the Aga Khan University Medical Centre, Karachi. J Clin Pathol 43:817-819. (Pubitemid 20296324)
27. Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW. 2003. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 63:812-816. (Pubitemid 36231981)
28. Vincenti V, Cassano C, Rocchi M, Persico G. 1996. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93:1493-1495. (Pubitemid 26115412)
29. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. 2000. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: Correlation with variation in VEGF protein production. Cytokine 12:1232-1235. (Pubitemid 30611801)
30. Yang B, Cross DF, Ollerenshaw M, Millward BA, Demaine AG. 2003. Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type1 diabetes mellitus. J Diabetes Complications 17:1-6. (Pubitemid 36042784)